Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
P-PEAKS UTI: Personalized-Phage Against E. Coli with IV Antibiotic to Knockout Stable Biofilms in Urinary Tract Infections
Pirnay, J.-P. (Promotor)
1/06/26 → 31/05/30
Project: Research › HORIZON
-
PHAGES-AntiPERS: Phage Therapy Antipersister strategy
Pirnay, J.-P. (Promotor)
1/04/25 → 31/03/28
Project: Research › Wallonia
-
RESILIENCE-R: First research action for Medical counter measures performed in the frame of the RESILIENCE FPA consortium
Pirnay, J.-P. (Promotor) & Martin, A. (Researcher)
1/11/24 → 31/10/27
Project: Research › EDF
-
Research in support of personalized bacteriophage therapy of difficult-to-treat infections
Merabishvili, M. (Researcher), Pirnay, J.-P. (Researcher), Steurs, G. (Researcher) & Cochez, C. (Researcher)
1/01/24 → 31/12/27
Project: Research › DFR
-
SynPhage : Synthetic Phage
Pirnay, J.-P. (Promotor), Glonti, T. (Researcher) & Goossens, M. (Researcher)
1/11/21 → 2/11/25
Project: Research
-
Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium
Willocx, M., Pirnay, J. P., Merabishvili, M., Laurent, F., Clouet, S., Lavigne, R., Ceyssens, P. J. & Vanhee, C., Jun 2026, In: European Journal of Pharmaceutics and Biopharmaceutics. 223, 115068.Research output: Contribution to journal › Article › peer-review
Open Access -
Rethinking informed consent in phage therapy: why location and approach matter
Nir-Paz, R., Pirnay, J. P., Ferry, T., Drulis-Kawa, Z., Classen, A. Y., Scobie, A. I., Lester, R., Katvan, E., Hafkemeyer, S., McCallin, S. & Suh, G. A., Aug 2026, In: Clinical Microbiology and Infection. 32, 8, p. 1211-1215 5 p.Research output: Contribution to journal › Comment/debate
-
Single Treatment of Mature 3D Single-, Dual- and Poly-Species Biofilms Using a Combination Therapy of Phage or Phage-Hetero-Cocktails and Ciprofloxacin
Glonti, T., Aktan, M. K., Cochez, C., Zayed, N., Braem, A., Teughels, W. & Pirnay, J. P., Jun 2026, In: Antibiotics. 15, 6, 537.Research output: Contribution to journal › Article › peer-review
Open Access -
Towards a reference methodology for bacteriophage susceptibility testing – position paper of the EUCAST Phage Susceptibility Testing Subcommittee
G.VukoticGoranEUCAST Phage Susceptibility Testing Subcommittee, 2026, (Accepted/In press) In: Clinical Microbiology and Infection.Research output: Contribution to journal › Comment/debate
-
Bacteriophage-based veterinary products: aligning regulatory framework and development challenges for market integration
Antoine, C., Mackay, D., Midtlyng, P., Kleppen, H. P., Palić, D., Pirnay, J. P., Thiry, D. & Thiry, E., Aug 2025, In: Biologicals. 91, 101847.Research output: Contribution to journal › Article › peer-review
Open Access10 Citations (Scopus)
-
Designing potent therapeutic cocktails using the naturally occurring bacteriophage grouping model
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
6 Sept 2024Activity: Talk or presentation › Oral scientific presentation
-
Burn or trauma scoring: experience of the burn unit of the Queen Astrid Military Hospital during the terror attacks on 22nd March 2016.
Bruyninckx, L. (Co-author), Jennes, S. (Co-author), Pirnay, J.-P. (Co-author) & de Schoutheete, J.-C. (Co-author)
28 Apr 2024Activity: Talk or presentation › Scientific poster presentation
-
Design of phage cocktails as a harness against antimicrobial resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
14 Sept 2024Activity: Talk or presentation › Oral scientific presentation
-
ADDRESSING RISK FACTORS MAY LEAD TO BROADER USE OF PHAGE THERAPEUTICS
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
15 Oct 2024Activity: Talk or presentation › Oral scientific presentation
Prizes
-
Martin Ramelot research prize
Pirnay, J.-P. (Recipient) & Merabishvili, M. (Recipient), 11 Oct 2009
Prize